The imidazoline derivative inhibitor market size has grown strongly in recent years. It will grow from $1.19 billion in 2023 to $1.26 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to a growing demand for imidazoline derivative inhibitors, the rising cost of corrosion-related damages, reducing toxic emissions and ensuring worker safety, and rapid industrial expansion, particularly in emerging markets.
The imidazoline derivative inhibitor market size is expected to see strong growth in the next few years. It will grow to $1.62 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The forecast period, growth is expected to be driven by heightened demand in agrochemicals, expanding industrial applications, a growing consumer preference for sustainable and environmentally friendly products, rapid industrialization and agricultural development, and increasing research and development activities. Key trends anticipated during this period include the development and adoption of bio-based imidazoline derivatives, the integration of nanotechnology to create more effective corrosion inhibitors, technological advancements in drug discovery, a greater emphasis on research and development activities, and innovations in synthesis and formulation technologies.
The increasing demand within the oil and gas industry is anticipated to drive the growth of the imidazoline derivative inhibitor market in the future. The oil and gas sector encompasses the exploration, extraction, refining, transportation, and marketing of oil and gas, playing a crucial role in the global economy by providing energy and raw materials for a variety of chemical products. Several factors, including economic growth, energy security, environmental policies, and global trade, contribute to the rising demand for the oil and gas industry. Imidazoline derivative inhibitors are essential for protecting metal surfaces in pipelines and equipment from corrosion caused by water and acids, which is critical for oil and gas operations. They also stabilize oil-water emulsions, improving separation efficiency, and are compatible with various surfactants and chemicals used in the industry. For example, the U.S. Energy Information Administration, a US government agency, reported that US oil production, which includes both crude oil and condensate, was 11.7 million barrels per day (b/d) in December 2021. This figure increased to 12.1 million b/d by 2022, highlighting a significant rise in production. Thus, the growing demand for the oil and gas industry is fueling the imidazoline derivative inhibitor market.
Companies in the imidazoline derivative inhibitor sector are concentrating on developing innovative products, such as ashless corrosion inhibitors, to gain a competitive advantage. An ashless corrosion inhibitor is a type of additive that prevents corrosion without leaving any solid residue or ash when subjected to high temperatures or during combustion. For instance, in January 2022, Cortec Corporation, a US-based provider of corrosion resistance solutions, introduced a new ashless corrosion inhibitor named M-535, designed specifically for turbine and gearbox oils. This advanced lubricant additive aims to enhance corrosion protection and compatibility for ashless oil systems, which are vital for various industrial applications. Unlike traditional corrosion inhibitors that only protect surfaces directly in contact with the oil, M-535 employs vapor-phase corrosion inhibitors. These molecules vaporize from the treated oil, forming a protective layer on metal surfaces above the fluid level. This feature ensures comprehensive protection even in systems that are not fully filled with oil, making it both cost-effective and efficient.
In January 2023, Prayon S.A., a Belgium-based company that specializes in phosphorus chemistry, acquired Febex from Arkema SA for an undisclosed amount. Through this acquisition, Prayon aims to strengthen its position in phosphorus chemistry, focusing on high-purity phosphoric acid production for the growing electronics and pharmaceutical markets. This deal also enhances Prayon's product diversification and industrial solutions related to purified phosphoric acid. Febex is a Switzerland-based provider of phosphoric acid in the electronics industry.
Major companies operating in the imidazoline derivative inhibitor market are BASF SE, Dow Chemical Company, Thermo Fisher Scientific Inc., Solvay S.A., Evonik Industries AG, LANXESS AG, Nouryon, Ashland Inc., The Lubrizol Corporation, Stepan Company, Croda International Plc, Kishida Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Colonial Chemical Inc., Strem Chemicals Inc., HPC Standards GmbH, LGC Limited, KANTO CHEMICAL CO. INC., BroadPharm, Junsei Chemical Co. Ltd., Qingdao Oceanview Chemical Inc., BOC Sciences.
North America was the largest region in the imidazoline derivative inhibitor market in 2023. The regions covered in the imidazoline derivative inhibitor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the imidazoline derivative inhibitor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Imidazoline derivative inhibitors are chemical compounds designed to prevent or reduce corrosion, particularly on metal surfaces. These inhibitors, derived from imidazoline, create a protective film over the metal, shielding it from damaging corrosive agents such as water, oxygen, and various chemicals. They are extensively utilized in industries such as oil and gas, where they help safeguard pipelines and equipment from harsh environmental conditions.
The primary types of imidazoline derivative inhibitors include alkyl benzothiazole, phosphonic acid, imidazoline amides, and imidazoline oligomers. Alkyl benzothiazole acts as a corrosion inhibitor by forming a protective film on metal surfaces to prevent oxidation. When combined with imidazoline derivative inhibitors, it enhances corrosion resistance, thereby prolonging the lifespan of metal structures. These inhibitors are distributed through various sales channels, including direct sales and distributors, and are applied in several sectors such as the chemical industry, laboratories, water treatment, oil and gas, pharmaceuticals, and pulp and paper.
The imidazoline derivative inhibitors market research report is one of a series of new reports that provides imidazoline derivative inhibitors market statistics, including imidazoline derivative inhibitors industry global market size, regional shares, competitors with an imidazoline derivative inhibitors market share, detailed imidazoline derivative inhibitors market segments, market trends, and opportunities, and any further data you may need to thrive in the imidazoline derivative inhibitors industry. This imidazoline derivative inhibitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The imidazoline derivative inhibitor market consists of sales of anxiolytics, antidiabetic agents, analgesics, and antihypertensives. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The imidazoline derivative inhibitor market size is expected to see strong growth in the next few years. It will grow to $1.62 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The forecast period, growth is expected to be driven by heightened demand in agrochemicals, expanding industrial applications, a growing consumer preference for sustainable and environmentally friendly products, rapid industrialization and agricultural development, and increasing research and development activities. Key trends anticipated during this period include the development and adoption of bio-based imidazoline derivatives, the integration of nanotechnology to create more effective corrosion inhibitors, technological advancements in drug discovery, a greater emphasis on research and development activities, and innovations in synthesis and formulation technologies.
The increasing demand within the oil and gas industry is anticipated to drive the growth of the imidazoline derivative inhibitor market in the future. The oil and gas sector encompasses the exploration, extraction, refining, transportation, and marketing of oil and gas, playing a crucial role in the global economy by providing energy and raw materials for a variety of chemical products. Several factors, including economic growth, energy security, environmental policies, and global trade, contribute to the rising demand for the oil and gas industry. Imidazoline derivative inhibitors are essential for protecting metal surfaces in pipelines and equipment from corrosion caused by water and acids, which is critical for oil and gas operations. They also stabilize oil-water emulsions, improving separation efficiency, and are compatible with various surfactants and chemicals used in the industry. For example, the U.S. Energy Information Administration, a US government agency, reported that US oil production, which includes both crude oil and condensate, was 11.7 million barrels per day (b/d) in December 2021. This figure increased to 12.1 million b/d by 2022, highlighting a significant rise in production. Thus, the growing demand for the oil and gas industry is fueling the imidazoline derivative inhibitor market.
Companies in the imidazoline derivative inhibitor sector are concentrating on developing innovative products, such as ashless corrosion inhibitors, to gain a competitive advantage. An ashless corrosion inhibitor is a type of additive that prevents corrosion without leaving any solid residue or ash when subjected to high temperatures or during combustion. For instance, in January 2022, Cortec Corporation, a US-based provider of corrosion resistance solutions, introduced a new ashless corrosion inhibitor named M-535, designed specifically for turbine and gearbox oils. This advanced lubricant additive aims to enhance corrosion protection and compatibility for ashless oil systems, which are vital for various industrial applications. Unlike traditional corrosion inhibitors that only protect surfaces directly in contact with the oil, M-535 employs vapor-phase corrosion inhibitors. These molecules vaporize from the treated oil, forming a protective layer on metal surfaces above the fluid level. This feature ensures comprehensive protection even in systems that are not fully filled with oil, making it both cost-effective and efficient.
In January 2023, Prayon S.A., a Belgium-based company that specializes in phosphorus chemistry, acquired Febex from Arkema SA for an undisclosed amount. Through this acquisition, Prayon aims to strengthen its position in phosphorus chemistry, focusing on high-purity phosphoric acid production for the growing electronics and pharmaceutical markets. This deal also enhances Prayon's product diversification and industrial solutions related to purified phosphoric acid. Febex is a Switzerland-based provider of phosphoric acid in the electronics industry.
Major companies operating in the imidazoline derivative inhibitor market are BASF SE, Dow Chemical Company, Thermo Fisher Scientific Inc., Solvay S.A., Evonik Industries AG, LANXESS AG, Nouryon, Ashland Inc., The Lubrizol Corporation, Stepan Company, Croda International Plc, Kishida Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Colonial Chemical Inc., Strem Chemicals Inc., HPC Standards GmbH, LGC Limited, KANTO CHEMICAL CO. INC., BroadPharm, Junsei Chemical Co. Ltd., Qingdao Oceanview Chemical Inc., BOC Sciences.
North America was the largest region in the imidazoline derivative inhibitor market in 2023. The regions covered in the imidazoline derivative inhibitor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the imidazoline derivative inhibitor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Imidazoline derivative inhibitors are chemical compounds designed to prevent or reduce corrosion, particularly on metal surfaces. These inhibitors, derived from imidazoline, create a protective film over the metal, shielding it from damaging corrosive agents such as water, oxygen, and various chemicals. They are extensively utilized in industries such as oil and gas, where they help safeguard pipelines and equipment from harsh environmental conditions.
The primary types of imidazoline derivative inhibitors include alkyl benzothiazole, phosphonic acid, imidazoline amides, and imidazoline oligomers. Alkyl benzothiazole acts as a corrosion inhibitor by forming a protective film on metal surfaces to prevent oxidation. When combined with imidazoline derivative inhibitors, it enhances corrosion resistance, thereby prolonging the lifespan of metal structures. These inhibitors are distributed through various sales channels, including direct sales and distributors, and are applied in several sectors such as the chemical industry, laboratories, water treatment, oil and gas, pharmaceuticals, and pulp and paper.
The imidazoline derivative inhibitors market research report is one of a series of new reports that provides imidazoline derivative inhibitors market statistics, including imidazoline derivative inhibitors industry global market size, regional shares, competitors with an imidazoline derivative inhibitors market share, detailed imidazoline derivative inhibitors market segments, market trends, and opportunities, and any further data you may need to thrive in the imidazoline derivative inhibitors industry. This imidazoline derivative inhibitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The imidazoline derivative inhibitor market consists of sales of anxiolytics, antidiabetic agents, analgesics, and antihypertensives. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Imidazoline Derivative Inhibitor Market Characteristics3. Imidazoline Derivative Inhibitor Market Trends And Strategies32. Global Imidazoline Derivative Inhibitor Market Competitive Benchmarking33. Global Imidazoline Derivative Inhibitor Market Competitive Dashboard34. Key Mergers And Acquisitions In The Imidazoline Derivative Inhibitor Market
4. Imidazoline Derivative Inhibitor Market - Macro Economic Scenario
5. Global Imidazoline Derivative Inhibitor Market Size and Growth
6. Imidazoline Derivative Inhibitor Market Segmentation
7. Imidazoline Derivative Inhibitor Market Regional And Country Analysis
8. Asia-Pacific Imidazoline Derivative Inhibitor Market
9. China Imidazoline Derivative Inhibitor Market
10. India Imidazoline Derivative Inhibitor Market
11. Japan Imidazoline Derivative Inhibitor Market
12. Australia Imidazoline Derivative Inhibitor Market
13. Indonesia Imidazoline Derivative Inhibitor Market
14. South Korea Imidazoline Derivative Inhibitor Market
15. Western Europe Imidazoline Derivative Inhibitor Market
16. UK Imidazoline Derivative Inhibitor Market
17. Germany Imidazoline Derivative Inhibitor Market
18. France Imidazoline Derivative Inhibitor Market
19. Italy Imidazoline Derivative Inhibitor Market
20. Spain Imidazoline Derivative Inhibitor Market
21. Eastern Europe Imidazoline Derivative Inhibitor Market
22. Russia Imidazoline Derivative Inhibitor Market
23. North America Imidazoline Derivative Inhibitor Market
24. USA Imidazoline Derivative Inhibitor Market
25. Canada Imidazoline Derivative Inhibitor Market
26. South America Imidazoline Derivative Inhibitor Market
27. Brazil Imidazoline Derivative Inhibitor Market
28. Middle East Imidazoline Derivative Inhibitor Market
29. Africa Imidazoline Derivative Inhibitor Market
30. Imidazoline Derivative Inhibitor Market Competitive Landscape And Company Profiles
31. Imidazoline Derivative Inhibitor Market Other Major And Innovative Companies
35. Imidazoline Derivative Inhibitor Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Imidazoline Derivative Inhibitor Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on imidazoline derivative inhibitor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for imidazoline derivative inhibitor? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The imidazoline derivative inhibitor market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Alkyl Benzothiazole; Phosphonic Acid; Imidazoline Amides; Imidazoline Oligomers2) By Sales Channel: Direct Sales; Distributors
3) By Application: Chemical Industry; Laboratory; Water Treatment; Oil And Gas; Pharmaceutical; Pulp And Paper
Key Companies Mentioned: BASF SE; Dow Chemical Company; Thermo Fisher Scientific Inc.; Solvay S.A.; Evonik Industries AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies profiled in this Imidazoline Derivative Inhibitor market report include:- BASF SE
- Dow Chemical Company
- Thermo Fisher Scientific Inc.
- Solvay S.A.
- Evonik Industries AG
- LANXESS AG
- Nouryon
- Ashland Inc.
- The Lubrizol Corporation
- Stepan Company
- Croda International Plc
- Kishida Chemical Co. Ltd.
- Tokyo Chemical Industry Co. Ltd.
- Colonial Chemical Inc.
- Strem Chemicals Inc.
- HPC Standards GmbH
- LGC Limited
- KANTO CHEMICAL CO. INC.
- BroadPharm
- Junsei Chemical Co. Ltd.
- Qingdao Oceanview Chemical Inc.
- BOC Sciences
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | December 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 1.26 Billion |
Forecasted Market Value ( USD | $ 1.62 Billion |
Compound Annual Growth Rate | 6.4% |
Regions Covered | Global |
No. of Companies Mentioned | 23 |